Isolation and in silico prediction of potential drug-like compounds from Anethum sowa L. root extracts targeted towards cancer therapy

Comput Biol Chem. 2019 Feb:78:242-259. doi: 10.1016/j.compbiolchem.2018.11.025. Epub 2018 Nov 30.

Abstract

Anethum sowa L. has been used as a spice herb in the Asian and European culinary systems to add flavour and taste. The studied plant has diverse folkloric medicinal value. Present study was designed to isolate phytochemicals from the hexane, chloroform and ethyl acetate extracts of the roots by various chromatographic techniques. Based on spectral analysis (IR, LC-MS, NMR) the isolated compounds were identified as physcione (1), β-sitosterol (2), stigmasterol (3), 2-oxo-3-propyl-2H-chromene-7-carboxylic acid (4), bergapten (5), 3-ethyl-7-hydroxy-2H-chromen-2-one (6) and graveolone (7). The mentioned compounds have been isolated for the first time from the roots part of the plant. Based on extensive literature review, physcione and bergapten were inferred to exhibit crucial bioactivities including inhibitory efficacy against various forms of cancer. Accordingly, in the present research approach molecular docking investigations of the isolated phytochemicals have been robustly executed with different oncogenes that have been reported to be actively involved in various forms of carcinoma. In silico investigations encompassing molecular docking analysis and drug-likeness profiling was executed to estimate the potential therapeutic tendencies of the phytochemicals targeted towards effective cancer therapy. Current investigation offers meaningful know-how pertaining to potential anticancer activities of the phytochemicals extracted from the roots of Anethum sowa L. and might open up new revenues towards effective drug development against cancer.

Keywords: 2-oxo-3-propyl-2H-chromene-7-carboxylic acid (PubChem CID: not found); 3-ethyl-7-hydroxy-2H-chromen-2-one (PubChem CID: 20230325); Anethum sowa; Anticancer; Bergapten (PubChem CID: 2355); Drug-likeness; Graveolone (PubChem CID: 177751); Molecular docking; Oncogenes; Physcione (PubChem CID: 10639); Root; Stigmasterol (PubChem CID: 5280794); β-sitosterol (PubChem CID: 222284).

MeSH terms

  • 5-Methoxypsoralen / chemistry
  • 5-Methoxypsoralen / isolation & purification
  • 5-Methoxypsoralen / pharmacology
  • Antineoplastic Agents, Phytogenic / chemistry
  • Antineoplastic Agents, Phytogenic / isolation & purification
  • Antineoplastic Agents, Phytogenic / pharmacology*
  • Apiaceae / chemistry*
  • Benzopyrans / chemistry
  • Benzopyrans / isolation & purification
  • Benzopyrans / pharmacology
  • Carboxylic Acids / chemistry
  • Carboxylic Acids / isolation & purification
  • Carboxylic Acids / pharmacology
  • Cell Proliferation / drug effects
  • Drug Screening Assays, Antitumor
  • Humans
  • Methoxsalen / analogs & derivatives
  • Methoxsalen / chemistry
  • Methoxsalen / isolation & purification
  • Methoxsalen / pharmacology
  • Molecular Docking Simulation*
  • Plant Extracts / chemistry
  • Plant Extracts / isolation & purification
  • Plant Extracts / pharmacology*
  • Plant Roots / chemistry*
  • Sitosterols / chemistry
  • Sitosterols / isolation & purification
  • Sitosterols / pharmacology
  • Stigmasterol / chemistry
  • Stigmasterol / isolation & purification
  • Stigmasterol / pharmacology

Substances

  • Antineoplastic Agents, Phytogenic
  • Benzopyrans
  • Carboxylic Acids
  • Plant Extracts
  • Sitosterols
  • graveoline
  • 5-Methoxypsoralen
  • gamma-sitosterol
  • Stigmasterol
  • Methoxsalen